Company news
Curis, Inc. news in 2019
Curis, Inc.'s news releases, calls and decks from 2019, newest first.
Curis Announces Positive Safety, Tolerability and Pharmacokinetic Data in Ongoing Phase 1 Study of Fimepinostat in Combination with Venetoclax
December 5, 2019
Curis Reports Third Quarter 2019 Financial Results
November 4, 2019
Curis to Release Third Quarter Financial Results and Hold Conference Call on November 5, 2019
October 28, 2019
Curis Reports Second Quarter 2019 Financial Results
August 5, 2019
Curis to Release Second Quarter Financial Results and Hold Conference Call on August 6, 2019
July 29, 2019
Curis Reports First Quarter 2019 Financial Results
May 13, 2019
Curis Completes Mesothelioma Enrollment in CA-170 Study
May 5, 2019
Decks in 2019
- 4th Waldenstrom Roadmap Symposium 2019
Conference · 26 slides · Apr 7, 2019